Ascites Syndrome and Pulmonary Hypertension in Broilers

Ascites syndrome, also known as pulmonary hypertension syndrome (PHS) in broilers, is a metabolic disorder characterized by the accumulation of clear, straw-colored fluid in the abdominal cavity (ascites) secondary to increased hydrostatic pressure in the hepatic portal and systemic venous circulation. The condition arises from a cascade of pathophysiological events initiated by increased cardiac output and pulmonary hypertension, leading to right ventricular hypertrophy, valvular insufficiency, and congestive heart failure. It is primarily a disease of fast-growing broiler chickens, particularly in high-altitude regions, but occurs worldwide. The syndrome is a major cause of morbidity and mortality in commercial broiler flocks, with significant economic losses due to increased mortality, reduced growth performance, and increased feed conversion ratio (FCR). Ascites syndrome is classified as a metabolic disease, often exacerbated by environmental, nutritional, and genetic factors. It affects broilers, occasionally turkeys, and rarely layers or breeders. The condition is multifactorial, with hypoxia, high energy diets, rapid growth rate, and cold stress being key triggers. The disease is of global importance, with prevalence ranging from 1% to 30% in affected flocks, depending on management and altitude.

The primary etiological factor is an imbalance between oxygen supply and demand, leading to hypoxia and subsequent pulmonary hypertension. This is often triggered by high altitude (hypobaric hypoxia), inadequate ventilation (hypercapnia), or increased metabolic rate due to rapid growth. Genetic selection for fast growth and high feed efficiency has increased susceptibility. Nutritional factors include high-energy diets, excess sodium, and deficiencies in antioxidants (vitamin E, selenium) or certain amino acids (e.g., arginine). Environmental stressors such as cold temperatures, dust, and ammonia can exacerbate the condition. Secondary etiologies include respiratory diseases (e.g., infectious bronchitis, aspergillosis) that impair gas exchange, and toxins (e.g., furazolidone, certain mycotoxins) that damage the heart or lungs. The syndrome is not caused by a single infectious agent but is a complex metabolic disorder.

Ascites syndrome predominantly affects broiler chickens, especially males, due to their higher growth rate and oxygen demand. It is most common in fast-growing strains, with peak incidence between 4 and 6 weeks of age. The disease is more prevalent in winter months and at high altitudes (above 1500 meters) due to lower oxygen partial pressure. Flocks with high stocking density, poor ventilation, and cold stress have increased incidence. Morbidity can reach 30% in severe outbreaks, and mortality typically ranges from 1% to 15%, but can be higher. The disease causes significant economic losses due to mortality, reduced weight gain, and increased FCR (by 0.1-0.2). Layers and breeders are rarely affected, but ascites can occur in broiler breeders, especially males, and in turkeys. Backyard poultry are less susceptible due to slower growth rates. The disease is worldwide, with higher prevalence in high-altitude regions like South America, Africa, and Asia.

The pathophysiology of ascites syndrome involves a cascade of events: 1) Increased metabolic rate and oxygen demand, especially in fast-growing broilers, leads to relative hypoxia. 2) Hypoxia triggers increased cardiac output and pulmonary vasoconstriction, leading to pulmonary hypertension. 3) Elevated pulmonary arterial pressure causes right ventricular hypertrophy and dilation (cor pulmonale). 4) Right heart failure leads to increased venous pressure in the hepatic portal system, causing transudation of fluid into the abdominal cavity (ascites). 5) The fluid accumulation compresses the lungs and further impairs gas exchange, creating a vicious cycle. 6) Hypoxia also stimulates erythropoiesis, leading to polycythemia and increased blood viscosity, further exacerbating pulmonary hypertension. 7) Endothelial damage and oxidative stress contribute to vascular remodeling. The liver becomes congested and fibrotic, and the kidneys may show degenerative changes. The syndrome is a classic example of congestive heart failure secondary to pulmonary hypertension.

Intrinsic factors include genetic susceptibility (fast-growing strains), male sex, young age (3-6 weeks), and high metabolic rate. Extrinsic factors include high altitude (hypobaric hypoxia), poor ventilation (elevated carbon dioxide and ammonia), cold stress, high-energy diets, excess dietary sodium, deficiencies in vitamin E, selenium, and arginine, and respiratory diseases (e.g., infectious bronchitis, aspergillosis). Management practices such as high stocking density, inadequate litter management, and excessive lighting programs that increase activity also predispose. Mycotoxins (e.g., fumonisins) and certain drugs (e.g., furazolidone) can directly damage the heart or lungs. The interaction of these factors increases the risk of ascites.

Clinical signs in affected flocks include increased mortality, especially in well-performing birds. Affected birds may show dyspnea, panting, and reluctance to move. Cyanosis of the comb, wattles, and skin is common. Birds often have a distended abdomen due to fluid accumulation, and may assume a 'penguin' posture. They may be smaller than flock mates and have poor feathering. In severe cases, sudden death occurs due to heart failure. Flock-level signs include reduced feed intake, decreased weight gain, and increased FCR. In layers, egg production may drop, but ascites is rare. The disease is often detected at processing when ascites is found at necropsy.

Differential diagnoses include: 1) Colibacillosis (E. coli infection) - causes airsacculitis, pericarditis, and perihepatitis, but ascites is less prominent; 2) Infectious bronchitis (IB) - respiratory signs and kidney damage, but ascites is not typical; 3) Aspergillosis - respiratory distress and granulomatous lesions in lungs, but no ascites; 4) Vitamin E/selenium deficiency - causes encephalomalacia and exudative diathesis, which can mimic ascites; 5) Congestive heart failure due to other causes (e.g., cardiomyopathy) - similar signs but less common; 6) Liver diseases (e.g., aflatoxicosis) - cause ascites due to hepatic fibrosis; 7) Salt poisoning - causes ascites and edema; 8) Right ventricular failure due to high altitude - same as ascites syndrome; 9) Lymphoid leukosis - causes tumors and ascites in older birds; 10) Hemorrhagic enteritis - causes bloody diarrhea and sudden death, but not ascites. Definitive diagnosis is based on necropsy findings of ascites, right ventricular hypertrophy, and pulmonary hypertension.

The diagnostic algorithm for ascites syndrome includes: 1) Flock history: high altitude, cold stress, fast-growing broilers, increased mortality. 2) Clinical observation: dyspnea, cyanosis, abdominal distension. 3) Gross necropsy: presence of clear, straw-colored fluid in the abdominal cavity, right ventricular hypertrophy (RV:TV ratio > 0.25), congested and edematous lungs, and congested liver. 4) Histopathology: pulmonary arteriolar hypertrophy, hepatic congestion and fibrosis, and myocardial hypertrophy. 5) Blood gas analysis: decreased partial pressure of oxygen (PaO2) and increased carbon dioxide (PaCO2). 6) Hematology: increased packed cell volume (PCV) and hemoglobin. 7) Rule out other causes of ascites (e.g., liver disease, salt poisoning) via histopathology and feed analysis. 8) Molecular diagnostics (PCR) for infectious agents if respiratory disease is suspected. 9) Environmental monitoring: oxygen levels, ammonia, and temperature. The diagnosis is primarily based on necropsy findings and history.

Serology: Not typically used for diagnosis, but may be used to rule out infectious causes (e.g., IBV ELISA). Molecular diagnostics: PCR for respiratory viruses (IBV, NDV) if secondary infection is suspected. Microbiology: Bacterial culture of liver/lungs to rule out colibacillosis. Coccidiosis lesion scoring: Not applicable. Mycotoxin feed assays: Check for fumonisins, aflatoxins, and other mycotoxins that may contribute. Blood chemistry: Increased PCV (often > 40%), increased hemoglobin, decreased PaO2, increased PaCO2, and metabolic acidosis. Liver enzymes (AST, ALT) may be elevated due to hepatic congestion. Electrolytes may show hyperkalemia. Histopathology: Pulmonary arteriolar medial hypertrophy, right ventricular hypertrophy, hepatic centrilobular congestion and fibrosis, and renal tubular degeneration.

Radiography: Not commonly used in live birds, but may show cardiomegaly and pulmonary edema. Ultrasonography: Can detect ascites and right ventricular dilation in live birds, but is rarely used in commercial practice. Gross necropsy photography: Essential for documentation; images show abdominal fluid, enlarged heart, and congested liver. Computed tomography (CT) and magnetic resonance imaging (MRI) are research tools, not used in field diagnosis.

Gross necropsy lesions: Accumulation of clear, straw-colored fluid in the abdominal cavity (often 50-200 ml), right ventricular hypertrophy and dilation, pulmonary edema and congestion, congested and swollen liver with rounded edges, and sometimes hydropericardium. Histopathology: Pulmonary arterioles show medial hypertrophy and hyperplasia, with increased smooth muscle. The right ventricle shows myocardial hypertrophy and fibrosis. The liver shows centrilobular congestion, sinusoidal dilation, and periportal fibrosis. The kidneys may show tubular degeneration and interstitial edema. The lungs show alveolar edema and congestion. These findings are characteristic of pulmonary hypertension and right heart failure.

Treatment of ascites syndrome is challenging and often unrewarding. Immediate measures include: 1) Improve ventilation to increase oxygen levels and reduce carbon dioxide and ammonia. 2) Reduce cold stress by adjusting heating and ventilation. 3) Reduce dietary energy and sodium, and increase vitamin C (250-500 mg/kg feed) and vitamin E (100-200 IU/kg feed) as antioxidants. 4) Administer diuretics such as furosemide (2-4 mg/kg IM or 10-20 mg/L drinking water) to reduce fluid accumulation, but this is not approved in all countries. 5) Use of cardiac glycosides (e.g., digoxin) is not recommended due to narrow safety margin. 6) Antibiotics are not indicated unless secondary bacterial infection is present. 7) In severe cases, culling affected birds is recommended. 8) Adjust lighting program to reduce activity and oxygen demand. 9) Use of feed restriction in early growth to slow growth rate and reduce oxygen demand. 10) In high-altitude areas, consider using slower-growing strains. Treatment is often ineffective, and prevention is key.

The prognosis for individual birds is poor; affected birds often die or are culled. Flock prognosis depends on the severity and management changes. With improved ventilation and dietary adjustments, mortality can be reduced, but the flock may still have reduced performance. In severe outbreaks, mortality can reach 15-30%, and FCR may be increased by 0.1-0.2. Egg production is not affected in broilers. Recovery is possible if environmental conditions are corrected early, but affected birds may have permanent cardiac damage. The long-term prognosis for the flock is guarded, and prevention is essential.

After an outbreak, monitor the flock closely for 2-3 weeks. Implement biosecurity and environmental improvements. Conduct regular necropsies to assess cardiac and pulmonary changes. Monitor blood gas and PCV if possible. Adjust feed formulation to reduce energy and sodium, and increase antioxidants. Review ventilation and heating systems. In subsequent flocks, consider using slower-growing strains or feed restriction programs. Conduct environmental monitoring for oxygen, ammonia, and temperature. Implement a vaccination program for respiratory diseases to reduce secondary infections. Document all findings for future reference.

Pearls: 1) Ascites is a diagnosis of exclusion; always rule out other causes of abdominal fluid. 2) Right ventricular hypertrophy (RV:TV ratio > 0.25) is a key necropsy finding. 3) High altitude and cold stress are major triggers; improve ventilation and heating. 4) Feed restriction in early growth can reduce incidence. 5) Vitamin C and E supplementation may help. Pitfalls: 1) Misdiagnosing ascites as colibacillosis or other infections; always culture if infection is suspected. 2) Overlooking environmental factors; always assess ventilation and temperature. 3) Using diuretics without addressing underlying causes; they are not a cure. 4) Ignoring genetic susceptibility; selecting for fast growth increases risk. 5) Failing to adjust feed formulation; high-energy diets exacerbate the condition. 6) Not considering mycotoxins; test feed for fumonisins and aflatoxins.

There are no specific drugs approved for ascites syndrome. Supportive treatments include: 1) Vitamin C (ascorbic acid) at 250-500 mg/kg feed or 1 g/L drinking water for 5-7 days, as an antioxidant. 2) Vitamin E at 100-200 IU/kg feed, combined with selenium (0.2-0.3 mg/kg feed). 3) Diuretics: Furosemide at 2-4 mg/kg IM or 10-20 mg/L drinking water for 3-5 days, but use with caution and check legal status. 4) Sodium bicarbonate at 0.5-1 g/L drinking water to correct acidosis, but not routinely recommended. 5) Antibiotics (e.g., amoxicillin 20 mg/kg or 250 mg/L drinking water for 3-5 days) only if secondary bacterial infection is confirmed. 6) In-feed anticoccidials are not relevant. 7) Vaccines: Not applicable for ascites, but ensure vaccination against respiratory diseases (IB, ND) to reduce respiratory stress. Withdrawal times must be observed for any medications.

Landmark studies include: 1) Julian et al. (1987) described the pathophysiology of ascites in broilers, linking high altitude and rapid growth. 2) Wideman et al. (2000) demonstrated the role of pulmonary hypertension and right ventricular failure. 3) Balog et al. (2003) showed that feed restriction reduces ascites incidence. 4) Scheele et al. (2003) highlighted genetic selection for growth as a risk factor. 5) Recent studies (e.g., Baghbanzadeh and Decuypere, 2008) reviewed nutritional interventions, including vitamin E and C. 6) AAAP guidelines recommend improving ventilation and reducing growth rate. 7) WOAH/OIE does not list ascites as a notifiable disease, but it is of economic importance. Consensus recommendations include: slow growth rate, optimize environment, and use antioxidants. Meta-analyses confirm that high altitude and cold stress are major triggers, and that feed restriction is effective in prevention.